GGrantIndex
← Leaderboards

Imbio, Llc

Minneapolis, MN

Compare ↔
$10,683,828
Total funding
9
Grants

Funding over time

peak $1.8M · FY201322
$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$10,683,828 · 9

By mechanism

R44$10,031,312 · 6
R43$652,516 · 3

Investigators at Imbio, Llc

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Largest grants

Personalized Smoking Cessation Tool Based on Patient Lung CT Image$622,479
R44 · FY2017 · CA
CT-based Biomarker for Diagnosis of COPD Phenotypes and Disease Progression$569,486
R44 · FY2014 · HL
CT-based Biomarker for Diagnosis of COPD Phenotypes and Disease Progression$564,374
R44 · FY2015 · HL
Commercialization of a CT-based Technique for BOS Assessment$553,577
R44 · FY2019 · HL
CT-based Biomarker for Diagnosis of COPD Phenotypes and Disease Progression$553,195
R44 · FY2016 · HL
Commercialization of the Shutter-Speed Model for Dynamic MRI in Cancer Diagnosis$551,816
R44 · FY2014 · CA
Commercialization of the Shutter-Speed Model for Dynamic MRI in Cancer Diagnosis$546,334
R44 · FY2015 · CA
Commercialization of the Shutter-Speed Model for Dynamic MRI in Cancer Diagnosis$541,200
R44 · FY2016 · CA
Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment$497,459
R44 · FY2017 · CA
Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment$489,069
R44 · FY2018 · CA
Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment$480,745
R44 · FY2019 · CA
Commercialization of a CT-based Technique for BOS Assessment$480,278
R44 · FY2020 · HL
Personalized Smoking Cessation Tool Based on Patient Lung CT Image$464,633
R44 · FY2016 · CA
Commercialization of a CT-based Technique for BOS Assessment$459,828
R44 · FY2021 · HL
Vascular Deformation Mapping (VDM) for Automated, 3D Assessment of Thoracic Aortic Aneurysm$449,993
R44 · FY2020 · HL
Vascular Deformation Mapping (VDM) for Automated, 3D Assessment of Thoracic Aortic Aneurysm$449,666
R44 · FY2022 · HL
Vascular Deformation Mapping (VDM) for Automated, 3D Assessment of Thoracic Aortic Aneurysm$449,666
R44 · FY2021 · HL
Personalized Smoking Cessation Tool Based on Patient Lung CT Image$400,151
R44 · FY2018 · CA
A CT-Based Multiparametric Imaging Biomarker for Assessment of Pediatric Interstitial Lung Disease$249,008
R43 · FY2022 · HL
Automated coronary artery calcification scoring for cardiovascular risk screening$224,403
R43 · FY2018 · HL